Cotinine Promotes Cancer Cell Proliferation and m1A RNA Methylation in Smoking-Associated Lung Cancer by Targeting PLK1/β-Catenin/TRMT6 Axis
Environment & Health · 21.08.2026 · 4 (8) · 1741-1753
DOI: 10.1021/envhealth.6c00013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environment & Health, online erschienen am 02.04.2026. Verfasst von Panlong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NA.
Abstract (Originalsprache)
Nicotine is the most abundant alkaloid in tobacco, and 70%–80% of its metabolites are cotinine. In terms of that, numerous cigarettes are consumed worldwide, resulting in a large amount of cotinine being released into the environment and posing potential hazards. However, the biological effects of cotinine are poorly understood. In the current study, we identified that the oncogene Polo-like kinase 1 (PLK1) is a direct target of cotinine, and cotinine could upregulate the protein level of PLK1. Public epidemiological data indicated a positive correlation between PLK1 expression and smoking. Subsequent studies validated that PLK1 directly interacted with β-catenin, leading to transcriptional activation of tRNA methyltransferase 6 (TRMT6), a canonical methyltransferase involved in m1A methylation modification of RNA. Dot blot showed that cotinine enhanced m1A RNA methylation in lung cancer cells. Public epidemiological data also demonstrated a positive correlation between the expression of TRMT6 and smoking. Knockdown of TRMT6 impaired cell proliferation and sensitized lung cancer cells to common chemotherapeutic agents. Taken together, our current study indicated a previously unknown role of cotinine in promoting cancer cell proliferation by targeting the PLK1/β-catenin/TRMT6 axis, which may shed light on the connection between smoking and RNA modifications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biotherapy Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
- Vaccine Research Institute, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
- Department of Oncology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
- Department of Spine Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
ORCID-Profile: Weicheng Liang
Förderung
- NA
Zitieren
APA
Li, P., Peng, X., Wu, S., Wang, J., Huang, Y., Lin, Z., Yang, Y., & Liang, W. (2026). Cotinine Promotes Cancer Cell Proliferation and m1A RNA Methylation in Smoking-Associated Lung Cancer by Targeting PLK1/β-Catenin/TRMT6 Axis. Environment & Health, 4(8), 1741-1753. https://doi.org/10.1021/envhealth.6c00013
Vancouver
Li P, Peng X, Wu S, Wang J, Huang Y, Lin Z, et al. Cotinine Promotes Cancer Cell Proliferation and m1A RNA Methylation in Smoking-Associated Lung Cancer by Targeting PLK1/β-Catenin/TRMT6 Axis. Environment & Health. 2026;4(8):1741-1753. doi:10.1021/envhealth.6c00013
BibTeX
@article{Li2026,
author = {Li, Panlong and Peng, Xuyun and Wu, Sihuang and Wang, Jiani and Huang, Yiju and Lin, Zexiao and Yang, Yang and Liang, Weicheng},
title = {Cotinine Promotes Cancer Cell Proliferation and m1A RNA Methylation in Smoking-Associated Lung Cancer by Targeting PLK1/β-Catenin/TRMT6 Axis},
journal = {Environment & Health},
year = {2026},
volume = {4},
number = {8},
pages = {1741--1753},
doi = {10.1021/envhealth.6c00013}
}
EUVIMED